The Drug Enforcement Administration has issued a notice of intent to place the opioids mitragynine and 7-hydroxymitragynine, which are the main active constituents in the plant kratom, in Schedule I under the temporary scheduling provisions of the Controlled Substances Act (81 Fed. Reg. 59929; Aug. 31, 2016). The action is based on a finding that emergency scheduling is necessary ... Read More